AI HORIZONS 2025 – Provolut

AI in Life Sciences

Modern enzyme based therapeutics

Dr. Ingmar Schuster (CEO Provolut) 

Classically used mostly in Enzyme Replacement Therapy, there are new and exciting uses of enzymes in therapy. The talk will touch on a new generation of enzymes for gene therapy as well as prodrug activation.